International Travel Patterns and Risk Behaviour of Breast Cancer, Lymphoma Patients and Bone Marrow Transplant Recipients

Completed

• Conditions: Breast Cancer; Lymphoma
• Interventions: Behavioral: questionnaires

• Registration Number: NCT01111201
• Lead Sponsor: Memorial Sloan Kettering Cancer Center

Brief Summary

This study also aims to raise awareness among both patients and health-care providers about the importance of pre-travel health consultation and preventive interventions prior to international travel.

Through appropriate health counseling, cancer patients will have less risk of having travel -related health complications and thus have a better quality of life and overall improved sense of wellbeing.

Detailed Description

Not available

Study Timeline

• Study Start: 2010-04
• Study First Submitted: 2010-04-22
• Study First Submitted QC: 2010-04-26
• Study First Posted: 2010-04-27
• Primary Completion: 2012-03
• Study Completion: 2012-03
• Status Verified: 2012-05
• Last Update Submitted: 2012-05-30
• Last Update Posted: 2012-06-01

Recruitment & Eligibility

• Status: COMPLETED
• Sex: All
• Target Recruitment: 26

Inclusion Criteria

• Hematopoietic Stem Cell Transplant (HSCT) recipients
• Age >18 years
• Status post bone marrow transplant within last five years Breast Cancer patients: Criteria 1 and Criteria 2 and/or 3
• Female age >18 years and current or past history of breast cancer
• Received systemic chemotherapy in the last five years
• Metastatic breast cancer disease (stage IV) Lymphoma: Criteria 1 and Criteria 2 and/or 3
• Age >18 years and current or past history of lymphoma
• Received systemic chemotherapy within 5 years
• Had active disease at any time within the last 5 years

Read More

Exclusion Criteria

• Patients age< 18 years
• Breast cancer and lymphoma patients in clinical remission in the past 5 years
• Patients unable to fill the questionnaire due to language barriers

Read More

Study & Design

• Study Type: OBSERVATIONAL
• Study Design: Not specified

Arm && Interventions

Group	Intervention	Description
questionnaires	questionnaires	There will be four versions of the questionnaire, each slightly modified to be more specific toward the treatment paradigms in the respective target patient population (Breast Cancer/ Lymphoma/Autologous Bone Marrow Transplant/ Allogeneic Bone Marrow Transplant). All questionnaire versions will consist of seven sections.

Primary Outcome Measures

Name	Time	Method
To determine the frequency of international travel of the targeted patients in the last 5 years.	once at the time of the clinic visit

Secondary Outcome Measures

Name	Time	Method
To determine if any of the international travel was during a high-risk specific period when the immune status of the target population was compromised.	once at the time of the clinic visit
To profile the target population who traveled internationally with respect to their demographic and cancer/transplant-related characteristics.	once at the time of the clinic visit
To obtain detailed information about their last international trip including	once at the time of the clinic visit
To assess the adequacy of the questionnaire instructions	once at the time of the clinic visit

Trial Locations

Locations (1)

Memorial Sloan Kettering Cancer Center; 🇺🇸 New York, New York, United States